Search Results for 'neuro-spinal scaffold'
-
Spine/Neurology
InVivo Therapeutics Attains 25 Percent Enrollment in Spinal Cord Injury Study
Fourteen sites currently are open for patient enrollment.Business Wire 12.09.19
-
Spine/Neurology
InVivo Therapeutics Enrolls First Two Patients in the INSPIRE 2.0 Study
Trial will examine the company's technology for treating acute spinal cord injury.Globe Newswire 07.24.19
-
InVivo Therapeutics Appoints New President and CEO
Acting chief executive is named permanently to the position.Business Wire 02.06.18
-
Spine/Neurology | Trauma/Sports
InVivo to Initiate Cervical Spinal Cord Injury Study
Company receives investigational testing authorization from Health Canada to conduct cervical spinal cord injury study.Business Wire 03.23.17
-
Spine/Neurology
New Patient Enrolled into InVivo Therapeutics' INSPIRE Study
Surgery and implantation performed on the T9 neurologically complete patient approximately 36 hours after injury occurred.Business Wire 11.17.16
-
Spine/Neurology
InVivo Therapeutics Receives Investigational Testing Authorization from Health Canada
Approval allows the company to enroll Canadian patients into its ongoing INSPIRE study.InVivo Therapeutics Holdings Corporation 07.18.16
-
Spine/Neurology
Two Additional Patients Implanted With InVivo's INSPIRE Scaffold in Expanded Clinical Trial
One patient suffered fatal stroke several days after implantation.Business Wire 07.14.16
-
Spine/Neurology
InVivo Adds Thomas Jefferson University Hospital to Study Sites
Study focuses on Neuro-Spinal Scaffold for thoracic and spinal cord injury patients.InVivo Therapeutics Holdings Corp. 03.08.16
-
Spine/Neurology
FDA Conditionally Approves Protocol Amendment for InVivo Neuro-Spinal Scaffold Trial
Study will now include patients in Canada and the U.K. as well as U.S.InVivo Therapeutics Holdings Corp. 12.03.15
-
Spine/Neurology
InVivo Adds Mount Sinai Hospital to Clinical Sites for Neuro-Spinal Scaffold Trial
The New York hospital brings the total number of sites to 14.09.15.15
-
Spine/Neurology
Two Promotions at InVivo Target Market Development of Neuro-Spinal Scaffold
Executives will lead business development, corporate communication and professional medical education.08.07.15
-
Biologics | Spine/Neurology
InVivo Therapeutics Adds Clinical Site to Pilot Study
A total of 12 facilities in 10 states now are enrolled.07.01.15
-
InVivo Expands Scope for Patent Covering Spinal Cord Injury Treatment Methods
Patent covers company’s investigational neuro-spinal scaffold.06.22.15
-
Spine/Neurology
Kansas Site Added to InVivo Neuro-Spinal Scaffold Trial
First trial patient was enrolled in October last year.03.30.15
-
Biologics
-
InVivo Reports Progress in Neuro-Spinal Scaffold Trial
Second subject enrolled and implanted successfully.01.23.15
-
InVivo Adds Sites to Neuro-Spinal Scaffold IDE Study
Enrollment will re-open after three-month observation of first patient.11.26.14
-
FDA Expands Trial Parameters for InVivo Biodegradable Neuro-Spinal Scaffold
Age limits, BMI allowance and injury levels have been increased.10.29.14
-
First Patient Enrolled In InVivo's Neuro-Spinal Scaffold Trial
Enrollment will re-open after three-month patient follow-up.10.16.14
-
InVivo Gets Go-Ahead for Patent Covering Neuro-Spinal Scaffold Technology
Technology is for open and closed wound spinal cord injuries.08.11.14
